These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23239811)
21. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism. Jeannot V; Busser B; Brambilla E; Wislez M; Robin B; Cadranel J; Coll JL; Hurbin A Int J Cancer; 2014 Jun; 134(11):2560-71. PubMed ID: 24374738 [TBL] [Abstract][Full Text] [Related]
22. BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC. Ba M; Long H; Yan Z; Wang S; Wu Y; Tu Y; Gong Y; Cui S J Cell Biochem; 2018 Jan; 119(1):973-982. PubMed ID: 28681984 [TBL] [Abstract][Full Text] [Related]
23. BMP4 depletion by miR-200 inhibits tumorigenesis and metastasis of lung adenocarcinoma cells. Kim JS; Kurie JM; Ahn YH Mol Cancer; 2015 Sep; 14():173. PubMed ID: 26395571 [TBL] [Abstract][Full Text] [Related]
24. Label-free quantitative proteomics and N-glycoproteomics analysis of KRAS-activated human bronchial epithelial cells. Sudhir PR; Chen CH; Pavana Kumari M; Wang MJ; Tsou CC; Sung TY; Chen JY; Chen CH Mol Cell Proteomics; 2012 Oct; 11(10):901-15. PubMed ID: 22761399 [TBL] [Abstract][Full Text] [Related]
25. Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas. McCleland ML; Adler AS; Deming L; Cosino E; Lee L; Blackwood EM; Solon M; Tao J; Li L; Shames D; Jackson E; Forrest WF; Firestein R Clin Cancer Res; 2013 Feb; 19(4):773-84. PubMed ID: 23224736 [TBL] [Abstract][Full Text] [Related]
26. Epigenetic silencing of cell adhesion molecule 1 in different cancer progenitor cells of transgenic c-Myc and c-Raf mouse lung tumors. Reamon-Buettner SM; Borlak J Cancer Res; 2008 Sep; 68(18):7587-96. PubMed ID: 18794147 [TBL] [Abstract][Full Text] [Related]
27. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma. Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804 [TBL] [Abstract][Full Text] [Related]
28. Identification of Epigenetic Biomarkers of Lung Adenocarcinoma through Multi-Omics Data Analysis. Kikutake C; Yahara K PLoS One; 2016; 11(4):e0152918. PubMed ID: 27042856 [TBL] [Abstract][Full Text] [Related]
29. Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: identification of the c-myc regulatory gene network. Reymann S; Borlak J BMC Syst Biol; 2008 May; 2():46. PubMed ID: 18498649 [TBL] [Abstract][Full Text] [Related]
30. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification]. Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740 [TBL] [Abstract][Full Text] [Related]
31. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers. Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088 [TBL] [Abstract][Full Text] [Related]
32. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma. Zhang QH; Dai XH; Dai ZM; Cai YN Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853 [TBL] [Abstract][Full Text] [Related]
33. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells. Edmiston JS; Yeudall WA; Chung TD; Lebman DA Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298 [TBL] [Abstract][Full Text] [Related]
34. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer. Zhong S; Fields CR; Su N; Pan YX; Robertson KD Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells. Dang X; Ma A; Yang L; Hu H; Zhu B; Shang D; Chen T; Luo Y Cancer Genet; 2012 Mar; 205(3):113-23. PubMed ID: 22469510 [TBL] [Abstract][Full Text] [Related]
36. Establishment of highly metastatic KRAS mutant lung cancer cell sublines in long-term three-dimensional low attachment cultures. Nakano T; Kanai Y; Amano Y; Yoshimoto T; Matsubara D; Shibano T; Tamura T; Oguni S; Katashiba S; Ito T; Murakami Y; Fukayama M; Murakami T; Endo S; Niki T PLoS One; 2017; 12(8):e0181342. PubMed ID: 28786996 [TBL] [Abstract][Full Text] [Related]
37. Interplay between menin and K-Ras in regulating lung adenocarcinoma. Wu Y; Feng ZJ; Gao SB; Matkar S; Xu B; Duan HB; Lin X; Li SH; Hua X; Jin GH J Biol Chem; 2012 Nov; 287(47):40003-11. PubMed ID: 23027861 [TBL] [Abstract][Full Text] [Related]